At 2 years, Black and white patients who received Lucentis for the treatment of diabetic macular edema achieved similar ...

The eyes are a window to the brain – and this outward extension of the central nervous system may reveal early signs of ...

Children with albinism and visual impairment demonstrate better visual search performance than other children with other visual impairments.

The company describes KSI-101 as a “novel, potent, and high-strength (100 mg/mL) antibody-based investigational therapy with ...

If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The allogenic cell therapy achieved all primary and ...

Two mechanisms of retinal impairment based on papilledema severity were identified among patients with idiopathic intracranial hypertension.

(HealthDay News) — Two mechanisms of structural and functional retinal impairment based on papilledema severity have been identified among patients with idiopathic intracranial hypertension (IIH), ...

Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, announced today follow-up ...

D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuity, control of retinal anatomy and reduction of treatment burden at all ...

83% (78/94) of patients demonstrated ocular tumor shrinkage, with 54% (51/94) achieving ≥20% tumor shrinkage 57% (24/42) eye preservation rate in enucleation (EN) recommended patients, which increased ...

If untreated, a disorder of high brain pressure called idiopathic intracranial hypertension can lead to vision loss. But this disorder can develop without noticeable symptoms, making it hard to catch.